Healthcare provider profile · identity verified

Leonard Muller, M.D.,

Internal Medicine · BROOLKYN, NY · NPI 1659349553

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Eliquis	Apixaban	483	50
Atorvastatin Calcium	Atorvastatin Calcium	462	69
Amlodipine Besylate	Amlodipine Besylate	334	61
Levothyroxine Sodium	Levothyroxine Sodium	324	50
Gabapentin	Gabapentin	261	43
Metoprolol Succinate	Metoprolol Succinate	249	52
Tamsulosin Hcl	Tamsulosin Hcl	248	51
Metoprolol Tartrate	Metoprolol Tartrate	246	54
Simvastatin	Simvastatin	223	34
Pantoprazole Sodium	Pantoprazole Sodium	220	49
Furosemide	Furosemide	196	41
Famotidine	Famotidine	190	41
Losartan Potassium	Losartan Potassium	186	35
Mirtazapine	Mirtazapine	181	33
Januvia	Sitagliptin Phosphate	177	16
Memantine Hcl	Memantine Hcl	168	27
Donepezil Hcl	Donepezil Hcl	166	37
Potassium Chloride	Potassium Chloride	158	25
Metformin Hcl	Metformin Hcl	132	23
Levetiracetam	Levetiracetam	124	23
Citalopram Hbr	Citalopram Hydrobromide	116	18
Lisinopril	Lisinopril	116	20
Clopidogrel	Clopidogrel Bisulfate	114	23
Quetiapine Fumarate	Quetiapine Fumarate	110	17
Escitalopram Oxalate	Escitalopram Oxalate	109	15
Trazodone Hcl	Trazodone Hcl	107	17
Clonazepam	Clonazepam	106	18
Omeprazole	Omeprazole	105	24
Finasteride	Finasteride	94	19
Latanoprost	Latanoprost	85	15
Xarelto	Rivaroxaban	84	suppressed
Hydralazine Hcl	Hydralazine Hcl	83	14
Duloxetine Hcl	Duloxetine Hcl	82	suppressed
Buspirone Hcl	Buspirone Hcl	77	14
Rosuvastatin Calcium	Rosuvastatin Calcium	73	20
Venlafaxine Hcl Er	Venlafaxine Hcl	72	suppressed
Pravastatin Sodium	Pravastatin Sodium	69	suppressed
Sertraline Hcl	Sertraline Hcl	69	suppressed
Aripiprazole	Aripiprazole	67	suppressed
Midodrine Hcl	Midodrine Hcl	62	12
Entresto	Sacubitril/Valsartan	57	suppressed
Baclofen	Baclofen	56	suppressed
Tramadol Hcl	Tramadol Hcl	56	11
Montelukast Sodium	Montelukast Sodium	53	14
Jardiance	Empagliflozin	48	suppressed
Prednisone	Prednisone	48	14
Rivastigmine	Rivastigmine Tartrate	48	suppressed
Allopurinol	Allopurinol	47	suppressed
Carvedilol	Carvedilol	47	suppressed
Azithromycin	Azithromycin	42	33
Olanzapine	Olanzapine	42	13
Carbidopa-Levodopa	Carbidopa/Levodopa	41	suppressed
Spironolactone	Spironolactone	41	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	40	suppressed
Topiramate	Topiramate	40	suppressed
Ondansetron Hcl	Ondansetron Hcl	39	25
Calcium Acetate	Calcium Acetate	38	suppressed
Farxiga	Dapagliflozin Propanediol	37	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	37	suppressed
Enalapril Maleate	Enalapril Maleate	36	suppressed
Humalog Kwikpen U-100	Insulin Lispro	36	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	35	suppressed
Silver Sulfadiazine	Silver Sulfadiazine	35	19
Digoxin	Digoxin	34	suppressed
Alprazolam	Alprazolam	33	suppressed
Cyclosporine	Cyclosporine	33	suppressed
Myrbetriq	Mirabegron	33	suppressed
Santyl	Collagenase Clostridium Hist.	32	suppressed
Torsemide	Torsemide	32	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	31	12
Lactulose	Lactulose	31	12
Sevelamer Carbonate	Sevelamer Carbonate	31	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	30	suppressed
Breo Ellipta	Fluticasone/Vilanterol	29	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	29	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	29	13
Fluticasone Propionate	Fluticasone Propionate	28	suppressed
Benztropine Mesylate	Benztropine Mesylate	27	suppressed
Atenolol	Atenolol	26	suppressed
Procrit	Epoetin Alfa	26	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	25	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Glipizide Er	Glipizide	25	suppressed
Lorazepam	Lorazepam	25	suppressed
Dextrose 5%-0.45% Nacl	Dextrose 5 %-0.45 % Sod Chlord	24	15
Insulin Lispro Kwikpen U-100	Insulin Lispro	24	suppressed
Labetalol Hcl	Labetalol Hcl	24	suppressed
Oxcarbazepine	Oxcarbazepine	24	suppressed
Glipizide	Glipizide	23	suppressed
Daptomycin	Daptomycin	22	suppressed
Meloxicam	Meloxicam	22	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	22	18
Methimazole	Methimazole	21	suppressed
Multaq	Dronedarone Hcl	21	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	21	suppressed
Potassium Citrate Er	Potassium Citrate	21	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	20	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	20	suppressed
Nystatin	Nystatin	20	14
Ssd	Silver Sulfadiazine	20	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	20	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	19	16
Azelastine Hcl	Azelastine Hcl	19	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	19	suppressed
Ranolazine Er	Ranolazine	19	suppressed
Risperidone Er	Risperidone Microspheres	19	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	19	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	18	15
Folic Acid	Folic Acid	18	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	18	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	18	suppressed
Valsartan	Valsartan	18	suppressed
Ceftriaxone	Ceftriaxone Sodium	17	13
Diclofenac Sodium	Diclofenac Sodium	17	suppressed
Ezetimibe	Ezetimibe	17	suppressed
Gentamicin Sulfate	Gentamicin Sulfate	17	14
Insulin Lispro	Insulin Lispro	17	suppressed
Linzess	Linaclotide	17	suppressed
Alphagan P	Brimonidine Tartrate	16	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	16	suppressed
Novolog	Insulin Aspart	16	suppressed
Sucralfate	Sucralfate	16	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	16	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	16	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	15	suppressed
Ciclopirox	Ciclopirox Olamine	15	11
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	15	suppressed
Ibuprofen	Ibuprofen	15	suppressed
Loteprednol Etabonate	Loteprednol Etabonate	15	suppressed
Metformin Hcl Er	Metformin Hcl	15	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	15	suppressed
Alogliptin	Alogliptin Benzoate	14	suppressed
Combigan	Brimonidine Tartrate/Timolol	14	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	14	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	14	suppressed
Levemir Flexpen	Insulin Detemir	14	suppressed
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Repaglinide	Repaglinide	14	suppressed
Sodium Chloride	0.9 % Sodium Chloride	14	suppressed
Solifenacin Succinate	Solifenacin Succinate	14	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	14	suppressed
Bumetanide	Bumetanide	13	suppressed
Glimepiride	Glimepiride	13	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	13	suppressed
Ketoconazole	Ketoconazole	13	suppressed
Oxycodone Hcl	Oxycodone Hcl	13	suppressed
Phenytoin	Phenytoin	13	suppressed
Retacrit	Epoetin Alfa-Epbx	13	suppressed
Spiriva Handihaler	Tiotropium Bromide	13	suppressed
Tamoxifen Citrate	Tamoxifen Citrate	13	suppressed
Vraylar	Cariprazine Hcl	13	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	12	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	12	suppressed
Meclizine Hcl	Meclizine Hcl	12	suppressed
Methadone Hcl	Methadone Hcl	12	suppressed
Pregabalin	Pregabalin	12	suppressed
Dorzolamide Hcl	Dorzolamide Hcl	11	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Humalog Mix 75-25	Insulin Lispro Protamin/Lispro	11	suppressed
Lacosamide	Lacosamide	11	suppressed
Nadolol	Nadolol	11	suppressed
Nifedipine Er	Nifedipine	11	suppressed
Nystatin-Triamcinolone	Nystatin/Triamcinolone Acet	11	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error